Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Eli Lilly and Company
Kivu Bioscience Inc.
MOMA Therapeutics
Astellas Pharma Inc
Edwards Lifesciences
Eli Lilly and Company
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Plexium, Inc.
Beijing Biotech
Parabilis Medicines, Inc.
Revolution Medicines, Inc.
Pfizer
Pfizer
USWM, LLC (dba US WorldMeds)
Coherus Oncology, Inc.
Lumos Pharma
Actuate Therapeutics Inc.
Conjupro Biotherapeutics, Inc.
Taiho Oncology, Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
IDEAYA Biosciences
Aulos Bioscience, Inc.
Buzzard Pharmaceuticals
iOnctura
Boston Scientific Corporation
Aptamer Sciences, Inc.
Erasca, Inc.
Novartis
Eli Lilly and Company
GlaxoSmithKline
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Orano Med LLC
Artios Pharma Ltd
Novartis
Frontier Medicines Corporation
Beijing Biotech
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Imugene Limited
I-Mab Biopharma US Limited
BicycleTx Limited
ViroMissile, Inc.
Engeneic Pty Limited
I-Mab Biopharma US Limited
Pfizer
Pfizer
Tizona Therapeutics, Inc